enow.com Web Search

  1. Ads

    related to: where to buy ingrezza sprinkle capsules over the counter benefits canada

Search results

  1. Results from the WOW.Com Content Network
  2. Valbenazine - Wikipedia

    en.wikipedia.org/wiki/Valbenazine

    Valbenazine, sold under the brand name Ingrezza, is a medication used to treat tardive dyskinesia. [1] It acts as a vesicular monoamine transporter 2 (VMAT2) inhibitor . [ 2 ]

  3. US FDA approves Neurocrine Biosciences' movement disorder ...

    www.aol.com/news/neurocrine-biosciences-hunting...

    The U.S. Food and Drug Administration (FDA) has approved the granule formulation of Neurocrine Biosciences' Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the ...

  4. Neurocrine Biosciences - Wikipedia

    en.wikipedia.org/wiki/Neurocrine_Biosciences

    In 2017, the company's drug valbenazine (Ingrezza) was approved in the US to treat adults with tardive dyskinesia (TD). [ 4 ] The company is also developing treatments that are in various stages of clinical research for Parkinson's disease , Tourette syndrome , and congenital adrenal hyperplasia [ 5 ] and with a partner for endometriosis and ...

  5. Over-the-counter drug - Wikipedia

    en.wikipedia.org/wiki/Over-the-counter_drug

    Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a requirement for a prescription from a healthcare professional, [1] as opposed to prescription drugs, which may be supplied only to consumers possessing a valid prescription.

  6. Neurocrine Biosciences Reports Mixed Q4 - AOL

    www.aol.com/finance/neurocrine-biosciences...

    Ingrezza continued to perform well in Q4, with net product sales reaching $615 million, marking a 23% year-over-year increase. This growth was primarily due to high patient demand and improved ...

  7. Why Is Neurocrine Biosciences Stock Trading Lower On Friday?

    www.aol.com/why-neurocrine-biosciences-stock...

    On Thursday, Neurocrine Biosciences Inc. (NASDAQ:NBIX) reported fourth-quarter adjusted EPS of $1.69, higher than the $1.54 reported a year ago, beating the consensus of $1.56. The company ...

  1. Ads

    related to: where to buy ingrezza sprinkle capsules over the counter benefits canada